Prosecution Insights
Last updated: April 19, 2026
Application No. 18/494,749

METHOD FOR MANUFACTURING CELLULOSE DERIVATIVE

Non-Final OA §102
Filed
Oct 25, 2023
Examiner
SCHACHERMEYER, SAMANTHA LYNN
Art Unit
1693
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Seiko Epson Corporation
OA Round
1 (Non-Final)
37%
Grant Probability
At Risk
1-2
OA Rounds
3y 7m
To Grant
99%
With Interview

Examiner Intelligence

Grants only 37% of cases
37%
Career Allow Rate
10 granted / 27 resolved
-23.0% vs TC avg
Strong +72% interview lift
Without
With
+71.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
46 currently pending
Career history
73
Total Applications
across all art units

Statute-Specific Performance

§101
5.2%
-34.8% vs TC avg
§103
41.4%
+1.4% vs TC avg
§102
17.7%
-22.3% vs TC avg
§112
28.9%
-11.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 27 resolved cases

Office Action

§102
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Claims 1-6 filed on 10/25/2023 are acknowledged. No preliminary amendment was filed. Priority This application claims foreign priority to JAPAN 2022-172298 filed on 10/27/2022. Information Disclosure Statement The information disclosure statement (IDS) dated 10/25/2023 complies with the provisions of 37 CFR 1.97, 1.98 and MPEP § 609. Accordingly, the IDS document has been placed in the application file and the information therein has been considered as to the merits. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-3 are rejected under 35 U.S.C. 102(a)(1)(a)(2) as being anticipated by Lin et al. (JP 6731105 B2, published 07/29/2020, see PTO-892). Lin is drawn to a sulfate ester modified cellulose nanofiber and a method for producing cellulose nanofiber. Lin exemplified the production of cellulose nanofibers with a crystallinity as low as 53% and exemplified the sulfate esterification of the cellulose nanofibers (Table 2). Lin teaches that the sulfate esterification was done by reacting the hydroxyl groups on the surface of the cellulose nanofiber to produce a sulfate esterified modified cellulose nanofiber (page 3). Accordingly, the instant claims are anticipated by teachings of the prior art. Claims 1-3 and 5-6 are rejected under 35 U.S.C. 102(a)(1)(a)(2) as being anticipated by Kimura et al. (JP 2010254798 A, published 11/11/2010, see PTO-892) and as evidenced by Wang et al. (Cellulose, 05/08/2018, see PTO-892). Kimura is drawn to a method for producing a cellulose ester. Kimura prepares a low crystalline cellulose by pulverizing pulp with a ball mill (page 7). Kimura claims a method of producing a cellulose ester compound by reacting a low crystalline powdery cellulose having a crystallization index of less than 5% in the presence of a base catalyst (claim 1, page 7-8). Kimura exemplified a low crystalline powdery cellulose with a crystallization index of -18% and average particle size of 45 micrometers that was reacted with a sodium methoxide/methanol solution, then the resulting product was reacted with methyl octoate. The resulting cellulose ester had a degree of substitution of 0.83 (Example 1, page 7). Kimura does not directly teach that the derivatization is esterification of the hydroxyl group of the low crystalline cellulose. As evidenced by Wang, the hydroxyl groups participate in the esterification reaction (page 3705 and Figure 1). Therefore, the esterification taught by Kimura must necessarily occur at the hydroxy group of the low crystalline cellulose meeting the limitation of instant claim 3. Accordingly, the instant claims are anticipated by teachings of the prior art. Claims 1, 2, and 4 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Liimatainen et al. (Carbohydrate Polymers, published 11/09/2010, see PTO-892). Liimatainen is drawn to the characterization of highly accessible cellulose microfibers generated by wet stirred media milling (title). The cellulose microfibers were produced from kraft wood pulp by a method based on a single mechanical treatment with a wet stirred media mill. The method resulted in microfibers with a length of below 50 micrometers. Further, the amount of reactive amorphous sites was increased according to the crystallinity index which decreased from 65% to 20-30% (page 2009). The chemical accessibility and reactivity of the micronized cellulose were evaluated by oxidizing cellulose to 2,3-dialdehyde cellulose during milling. The product of the evaluation step meets the limitation of derivatizing the cellulose (page 2006). Accordingly, the instant claims are anticipated by teachings of the prior art. Conclusion No claims allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SAMANTHA LYNN SCHACHERMEYER whose telephone number is (703)756-5337. The examiner can normally be reached Monday thru Friday, alternate Fridays off, 7:30AM-5PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Goon can be reached on (571) 270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SAMANTHA LYNN SCHACHERMEYER/Examiner, Art Unit 1693 /SCARLETT Y GOON/Supervisory Patent Examiner, Art Unit 1693
Read full office action

Prosecution Timeline

Oct 25, 2023
Application Filed
Feb 06, 2026
Non-Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594258
INHIBITORS OF MHC-I NEF DOWNMODULATION FOR TREATING HIV
2y 5m to grant Granted Apr 07, 2026
Patent 12582656
NUCLEOTIDE ANALOGUES
2y 5m to grant Granted Mar 24, 2026
Patent 12545699
BIVALENT LECA INHIBITORS TARGETING BIOFILM FORMATION OF PSEUDOMONAS AERUGINOSA
2y 5m to grant Granted Feb 10, 2026
Patent 12516081
ANTI-VIRAL COMPOUNDS AND METHODS OF USE
2y 5m to grant Granted Jan 06, 2026
Patent 12465644
PHARMACEUTICAL COMPOSITION CONTAINING STABILIZED NUCLEIC ACID ADJUVANT
2y 5m to grant Granted Nov 11, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
37%
Grant Probability
99%
With Interview (+71.7%)
3y 7m
Median Time to Grant
Low
PTA Risk
Based on 27 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month